CFO
PODD icon

Callan Family Office’s Insulet PODD Stock Holding History

Callan Family Office’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Buy
1,860
+370
+25% +$61.6K 0.01% 1025
2026
Q1 		$313K Buy
1,490
+28
+2% +$7.04K 0.01% 916
2025
Q4 		$416K Buy
1,462
+374
+34% +$117K 0.01% 831
2025
Q3 		$336K Sell
1,088
-105
-9% -$32.9K 0.01% 661
2025
Q2 		$375K Buy
+1,193
New +$344K 0.01% 695

Other funds holding PODD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Callan Family Office's PODD Position: Q2 2026 in Review

Callan Family Office increased its Insulet (PODD) stake by 25% in Q2 2026, buying an estimated $61.6K and bringing the position to 1,860 shares worth $283K. The position accounts for 0.01% of the portfolio, ranked #1025.

Callan Family Office first reported a position in PODD in Q2 2025 and has held it in 5 quarters since. The position peaked at $416K in Q4 2025. 731 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Callan Family Office held 1,860 shares of Insulet worth $283K as of Q2 2026.
  • Callan Family Office bought 370 Insulet shares in Q2 2026, an estimated $61.6K.
  • Insulet made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #1025 holding.
  • Callan Family Office first reported a position in Insulet in Q2 2025 and has held it in 5 quarters since.
  • Callan Family Office's Insulet position peaked at $416K in Q4 2025.
  • 731 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.